CAS RN: 1589565-36-5
tert-butyl (S)-2-(cyanomethyl)piperazine-1-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260127 |
100mg / 250mg / 1g |
Confirm by inquiry |
Shanghai, Shandong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 5g, 1g, 0.25g, 10g, 25g
- Available purity: >95%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1589565-36-5
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>95% |
4
In Stock
|
Hong Kong |
Inquiry |
| 1g |
>95% |
3
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>95% |
2
In Stock
|
Shanghai |
Inquiry |
| 10g |
>95% |
2
In Stock
|
Hong Kong |
Inquiry |
| 25g |
>95% |
0
Out of Stock
|
Shanghai |
Inquiry |
1589565-36-5 / tert-butyl (2S)-2-(cyanomethyl)piperazine-1-carboxylate
Standard CAS: 1589565-36-5
Multi CAS: No
Basic Information
CAS
1589565-36-5
Multi CAS
No
Molecular Formula
C11H19N3O2
Molecular Weight
225.290000
Exact Mass
225.147727
SMILES
CC(C)(C)OC(=O)N1CCNC[C@@H]1CC#N
InChI
InChI=1S/C11H19N3O2/c1-11(2,3)16-10(15)14-7-6-13-8-9(14)4-5-12/h9,13H,4,6-8H2,1-3H3/t9-/m0/s1
InChIKey
BTWCKQOWWVNXTC-VIFPVBQESA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Fraction Csp3
0.82
Rotatable bonds
1
H-bond acceptors
4
H-bond donors
1
Molar refractivity
59.83
TPSA
65.36
LogP / Solubility
WLOGP
1.11
MLOGP
0.98
XLogP3
0.2
Consensus LogP
0.76
Log S (ESOL)
-1.87
Class (ESOL)
Soluble
Log S (Ali)
-2.21
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.16
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.31
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2